ArticleFrontiers in oncology2021

Case Report: Anlotinib Therapy in a Patient With Recurrent and Metastatic RAIR-DTC Harboring Coexistent TERT Promoter and BRAF

Yanjun Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.